Monday morning at the pre-bell, and the market is already testing your ability to stay sober.
[GAINER] $EDBL is ripping +132% on news of a Walmart distribution deal... for fresh-cut herbs. A $2M microcap is gapping like it cured aging because of some retail parsley. Historically, catalyst-driven gap-ups of this size close red 65% of the time across 2,881 similar setups.
Across the ledger, [LOSER] $MPLT crumbles -63% despite announcing "positive" Phase 2 trial results. Welcome to biotech, where major clinical success is treated as a liquidity exit event.
If you are buying the thyme-and-rosemary pump or catching the clinical falling knife before the open, step away from the order screen and go make some coffee.